Authors:
EUCHENHOFER C
MAIHOFNER C
BRUNE K
TEGEDER I
GEISSLINGER G
Citation: C. Euchenhofer et al., DIFFERENTIAL EFFECT OF SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR NS-398 AND DICLOFENAC ON FORMALIN-INDUCED NOCICEPTION IN THE RAT, Neuroscience letters, 248(1), 1998, pp. 25-28
Authors:
BREMER F
LOTSCH J
BRUNE K
SCHUTTLER J
GEISSLINGER G
TEGEDER I
Citation: F. Bremer et al., COMPARISON OF PHARMACOKINETICS OF MEROPENEM AND IMIPENEM IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 623-623
Authors:
CRIEGEERIECK M
LOTSCH J
TEGEDER I
GUHRING H
GEISSLINGER G
Citation: M. Criegeerieck et al., TEACHING CLINICAL-PHARMACOLOGY WITH ADVANCED MULTIMEDIA AND INTERNET TECHNOLOGIES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 625-625
Authors:
TEGEDER I
MUTHSELBACH U
OELKERS R
LOTSCH J
BRUNE K
SORGEL F
GEISSLINGER G
Citation: I. Tegeder et al., APPLICATION OF HUMAN MICRODIALYSIS FOR THE EVALUATION OF TISSUE IBUPROFEN CONCENTRATIONS AFTER PERORAL AND TOPICAL ADMINISTRATION, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 641-641
Authors:
MUTHSELBACH U
TEGEDER I
KREBS S
NEUPERT W
BRUNE K
GEISSLINGER G
Citation: U. Muthselbach et al., EFFECTS OF MELOXICAM AND DICLOFENAC ON HUMAN THROMBOXANE BIOSYNTHESIS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 652-652
Authors:
ERB K
LIEBEL JT
TEGEDER I
ZEILHOFER HU
BRUNE K
GEISSLINGER G
Citation: K. Erb et al., SPINALLY DELIVERED NOCICEPTIN ORPHANIN FQ REDUCES FLINCHING BEHAVIOR IN THE RAT FORMALIN TEST/, NeuroReport, 8(8), 1997, pp. 1967-1970
Authors:
TEGEDER I
SCHUMACHER A
JOHN S
GEIGER H
GEISSLINGER G
BANG H
BRUNE K
Citation: I. Tegeder et al., ELEVATED SERUM CYCLOPHILIN LEVELS IN PATIENTS WITH SEVERE SEPSIS, Journal of clinical immunology, 17(5), 1997, pp. 380-386
Authors:
TEGEDER I
BREMER F
OELKERS R
SCHOBEL H
SCHUTTLER J
BRUNE K
GEISSLINGER G
Citation: I. Tegeder et al., PHARMACOKINETICS OF IMIPENEM-CILASTATIN IN CRITICALLY ILL PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2640-2645
Authors:
TEGEDER I
BREMER F
OELKERS R
SCHUTTLER J
BRUNE K
GEISSLINGER G
Citation: I. Tegeder et al., THERAPEUTIC DRUG-MONITORING OF IMIPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 485-485